Microdosing may be an option for many people, but you should always talk with your provider before changing your dose
It is linked to a broader CMS initiative known as the BALANCE model, which was originally envisioned as a longer-term framework for integrating weight management treatments into Medicare
Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
Microdosing GLP-1 involves taking a much lower dose than standardly prescribed, typically administered by a weekly injection and compounded to minimize any potential side effects
Nadkarni, P., Chepurny, O
Thomas NJ, Lynam AL, Hill AV et al (2019) Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes